We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Supreme Court last Tuesday heard oral argument in Sorrell, et al. v. IMS Health, Inc., et al., a case concerning the constitutionality of a law that impacts the ways in which pharmaceutical manufacturers may market their products
Current Search
Workarea - Media & Entertainment
Workarea - Litigation
Workarea - Healthcare
Firm Name - Paul, Weiss, Rifkind, Wharton & Garrison LLP
